carbamazepine brands
12 registered brands containing carbamazepine in Zambia.
2D structure
Carbamazepine
PubChem CID 2554Molecular formula: C15H12N2O
Carbamazepine's mechanism of action is not fully elucidated and is widely debated. One major hypothesis is that carbamazepine inhibits sodium channel firing, treating seizure activity. Animal research studies have demonstrated that carbamazepine exerts its effects by lowering polysynaptic nerve response and inhibiting post-tetanic potentiation. In both cats and rats, carbamazepine was shown to decrease pain caused by infraorbital nerve stimulation. A decrease in the action potential in the nucleus ventralis of the thalamus in the brain and inhibition of the lingual mandibular reflex were observed in other studies after carbamazepine use. Carbamazepine causes the above effects by binding to voltage-dependent sodium channels and preventing action potentials, which normally lead to stimulatory effects on nerves. In bipolar disorder, carbamazepine is thought to increase dopamine turnover and increase GABA transmission, treating manic and depressive symptoms. A common issue that has arisen is resistance to this drug in up to 30% of epileptic patients, which may occur to altered metabolism in patients with variant genotypes. A potential therapeutic target to combat carbamazepine resistance has recently been identified as the EPHX1 gene promoter, potentially conferring resistance to carbamazepine through methylation. Anticonvulsant: Exact mechanism unknown; may act postsynaptically by limiting the ability of neurons to sustain high frequency repetitive firing of action potentials through enhancement of sodium channel inactivation; in addition to altering neuronal excitability, may act presynaptically to block the release of neurotransmitter by blocking presynaptic sodium channels and the firing of action potentials, which in turn decreases synaptic transmission. Antineuralgic: Exact mechanism unknown; may involve gamma-aminobutyric acid (GABAB) receptors, which may be linked to calcium channels. Antimanic; antipsychotic: Exact mechanism is unknown; may be related to either the anticonvulsant or the antineuralgic effects of carbamazepine, or to tis effects on neurotransmitter modulator systems. Antidiuretic: Exact mechanism unknown; may exert a hypothalamic effect on the osmoreceptors mediated via secretion of antidiuretic hormone (ADH), or may have a direct effect on the renal tubule. For more Mechanism of Action (Complete) data for CARBAMAZEPINE (8 total), please visit the HSDB record page.
Source: PubChem (NCBI) · compound 2554
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| CARBAMAZEPINE TABLETS BP 200mg Tablet Uncoated |
Kausikh Therapeutic | Registered/Compliant | Zambia |
| Carbamazepine Tablets BP 200mg Tablet Uncoated |
Yash Life Sciences | Registered/Compliant | Zambia |
| Carbamezapine tablets Tablet Uncoated |
Lincoln Parenteral | Registered/Compliant | Zambia |
| Degranol 200 tablets Tablet Uncoated |
Aspen | Registered/Compliant | Zambia |
| Karbapin tablets Tablet Uncoated |
Pharmalink Laboratories | Registered/Compliant | Zambia |
| Neurotrol 200 mg Tablet Uncoated |
Universal Corporation | Registered/Compliant | Zambia |
| Tegretol Tablet Uncoated |
Novartis | Registered/Compliant | Zambia |
| Tegretol 200mg Tablets Tablet+ Film-coated |
Novartis | Registered/Compliant | Zambia |
| Tegretol CR tablets Tablet Uncoated |
Norvatis Pharma Stein AG And Norvatis Farmaceutica SA | Registered/Compliant | Zambia |
| Tegretol Oral Suspension Suspension for Oral Use |
Novartis | Registered/Compliant | Zambia |
| Tegretol syrup Oral Suspension |
Novartis | Registered/Compliant | Zambia |
| TEGRETOL® 400 CR Tablet Uncoated |
Novartis | Registered/Compliant | Zambia |